Anti-Notch-1 monoclonal antibody
Alternative Names: Monoclonal antibody Notch-1; Notch-1 monoclonal antibodyLatest Information Update: 09 Dec 2003
At a glance
- Originator National Institutes of Health (USA)
- Class Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 09 Dec 2003 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 30 Nov 2000 Preclinical development for Cancer in USA (Unknown route)